Similar articles

• Clinical relevance of endothelium-derived relaxing factor (EDRF).

  Bassenge E. Bassenge E. Br J Clin Pharmacol. 1992;34 Suppl 1(Suppl 1):37S-42S. doi: 10.1111/j.1365-2125.1992.tb04147.x. Br J Clin Pharmacol. 1992. PMID: 1633078 Free PMC article. Review.
• L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation.

  Kown MH, van Der Steenhoven T, Uemura S, Jahncke CL, Hoyt GE, Rothbard JB, Robbins RC. Kown MH, et al. Transplantation. 2001 Jun 15;71(11):1542-8. doi: 10.1097/00007890-200106150-00010. Transplantation. 2001. PMID: 11435962
• Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.

  Koifman B, Topilski I, Megidish R, Zelmanovich L, Chernihovsky T, Bykhovsy E, Keren G. Koifman B, et al. Am J Cardiol. 2006 Jul 15;98(2):172-7. doi: 10.1016/j.amjcard.2006.01.085. Epub 2006 May 12. Am J Cardiol. 2006. PMID: 16828587
• Endothelial function and nitric oxide: clinical relevance.

  Vallance P, Chan N. Vallance P, et al. Heart. 2001 Mar;85(3):342-50. doi: 10.1136/heart.85.3.342. Heart. 2001. PMID: 11179281 Free PMC article. Review. No abstract available.
• Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.

  Voisine P, Li J, Bianchi C, Khan TA, Ruel M, Xu SH, Feng J, Rosinberg A, Malik T, Nakai Y, Sellke FW. Voisine P, et al. Circulation. 2005 Aug 30;112(9 Suppl):I202-7. doi: 10.1161/CIRCULATIONAHA.104.526350. Circulation. 2005. PMID: 16159817